-
1
-
-
0029826062
-
Reteplase: A review of its pharmacological properties and clinical efficacy in the management of acute myocardial infarction
-
Oct;
-
Noble S, McTavish D. Reteplase: a review of its pharmacological properties and clinical efficacy in the management of acute myocardial infarction. Drugs 1996 Oct; 52: 589-605
-
(1996)
Drugs
, vol.52
, pp. 589-605
-
-
Noble, S.1
McTavish, D.2
-
2
-
-
33846896097
-
-
Protein Design Labs Inc, Fremont CA, PDL Biopharma Inc, Dec
-
Protein Design Labs Inc. Retavase® (reteplase) prescribing information. Fremont (CA): PDL Biopharma Inc., 2005 Dec
-
(2005)
Retavase® (reteplase) prescribing information
-
-
-
3
-
-
0032906274
-
Current clinical use of reteplase for thrombolysis: A pharmacokinetic-pharmacodynamic perspective
-
Apr;
-
Martin U, Kaufmann B, Neugebauer G. Current clinical use of reteplase for thrombolysis: a pharmacokinetic-pharmacodynamic perspective. Clin Pharmacokinet 1999 Apr; 36: 265-76
-
(1999)
Clin Pharmacokinet
, vol.36
, pp. 265-276
-
-
Martin, U.1
Kaufmann, B.2
Neugebauer, G.3
-
4
-
-
0026595548
-
Evaluation of thrombolytic and systemic effects of the novel recombinant plasminogen activator BM 06.022 compared with alteplase, anistreplase, streptokinase and urokinase in a canine model of coronary artery thrombosis
-
Martin U, Sponer G, Strein K. Evaluation of thrombolytic and systemic effects of the novel recombinant plasminogen activator BM 06.022 compared with alteplase, anistreplase, streptokinase and urokinase in a canine model of coronary artery thrombosis. J Am Coll Cardiol 1992; 19: 433-40
-
(1992)
J Am Coll Cardiol
, vol.19
, pp. 433-440
-
-
Martin, U.1
Sponer, G.2
Strein, K.3
-
5
-
-
0034643938
-
High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: Results from TIMI (Thrombolysis in Myocardial Infarction) 14. The TIMI 14 Platelet Substudy Investigators
-
Jun 13;
-
Coulter SA, Cannon CP, Ault KA, et al. High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: results from TIMI (Thrombolysis in Myocardial Infarction) 14. The TIMI 14 Platelet Substudy Investigators. Circulation 2000 Jun 13; 101: 2690-5
-
(2000)
Circulation
, vol.101
, pp. 2690-2695
-
-
Coulter, S.A.1
Cannon, C.P.2
Ault, K.A.3
-
6
-
-
27944489616
-
Combined thrombolysis with abciximab favourably influences platelet-leukocyte interactions and platelet activation in acute myocardial infarction
-
Dec;
-
Szabo S, Etzel D, Ehlers R, et al. Combined thrombolysis with abciximab favourably influences platelet-leukocyte interactions and platelet activation in acute myocardial infarction. J Thromb Thrombolysis 2005 Dec; 20 (3): 155-61
-
(2005)
J Thromb Thrombolysis
, vol.20
, Issue.3
, pp. 155-161
-
-
Szabo, S.1
Etzel, D.2
Ehlers, R.3
-
7
-
-
9144219772
-
Effect of abciximab on prothrombin activation and thrombin generation in patients with acute myocardial infarction also receiving reteplase
-
Jan 15;
-
Merlini PA, Repetto A, Andreoli AM, et al. Effect of abciximab on prothrombin activation and thrombin generation in patients with acute myocardial infarction also receiving reteplase. Am J Cardiol 2004 Jan 15; 93 (2): 195-8
-
(2004)
Am J Cardiol
, vol.93
, Issue.2
, pp. 195-198
-
-
Merlini, P.A.1
Repetto, A.2
Andreoli, A.M.3
-
8
-
-
0026012337
-
Pharmacokinetic and hemostatic properties of the recombinant plasminogen activator BM 06.022 in healthy volunteers
-
Martin U, von Möllendorff E, Akpan W, et al. Pharmacokinetic and hemostatic properties of the recombinant plasminogen activator BM 06.022 in healthy volunteers. Thromb Haemost 1991; 66: 569-74
-
(1991)
Thromb Haemost
, vol.66
, pp. 569-574
-
-
Martin, U.1
von Möllendorff, E.2
Akpan, W.3
-
9
-
-
0026047886
-
Dose-ranging study of the novel recombinant plasminogen activator BM 06.022 in healthy volunteers
-
Martin U, von Möllendorff E, Akpan W, et al. Dose-ranging study of the novel recombinant plasminogen activator BM 06.022 in healthy volunteers. Clin Pharmacol Ther 1991; 50: 429-36
-
(1991)
Clin Pharmacol Ther
, vol.50
, pp. 429-436
-
-
Martin, U.1
von Möllendorff, E.2
Akpan, W.3
-
11
-
-
0030713356
-
Double- versus single-bolus thrombolysis with reteplase for acute myocardial infarction: A pharmacokinetic and pharmacodynamic study
-
May;
-
Grunewald M, Muller M, Ellbruck D, et al. Double- versus single-bolus thrombolysis with reteplase for acute myocardial infarction: a pharmacokinetic and pharmacodynamic study. Fibrinolysis Proteolysis 1997 May; 11: 137-45
-
(1997)
Fibrinolysis Proteolysis
, vol.11
, pp. 137-145
-
-
Grunewald, M.1
Muller, M.2
Ellbruck, D.3
-
12
-
-
0029560188
-
Uptake, internalization and degradation of the novel plasminogen activator reteplase (BM 06.022) in the rat
-
Kuiper J, van de Bilt H, Martin U, et al. Uptake, internalization and degradation of the novel plasminogen activator reteplase (BM 06.022) in the rat. Thromb Haemost 1995; 74: 1501-10
-
(1995)
Thromb Haemost
, vol.74
, pp. 1501-1510
-
-
Kuiper, J.1
van de Bilt, H.2
Martin, U.3
-
13
-
-
0343849937
-
Randomized comparison of coronary thrombolysis achieved with double bolus reteplase (r-PA) and front-loaded, "accelerated" alteplase (rt-PA) in patients with acute myocardial infarction
-
Sep 1;
-
Bode C, Smalling RW, Berg G, et al. Randomized comparison of coronary thrombolysis achieved with double bolus reteplase (r-PA) and front-loaded, "accelerated" alteplase (rt-PA) in patients with acute myocardial infarction. Circulation 1996 Sep 1; 94 (5): 891-8
-
(1996)
Circulation
, vol.94
, Issue.5
, pp. 891-898
-
-
Bode, C.1
Smalling, R.W.2
Berg, G.3
-
14
-
-
0029066701
-
More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction
-
Smalling RW, Bode C, Kalbfleisch J. More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. Circulation 1995; 91: 2725-32
-
(1995)
Circulation
, vol.91
, pp. 2725-2732
-
-
Smalling, R.W.1
Bode, C.2
Kalbfleisch, J.3
-
15
-
-
0030879325
-
A comparison of reteplase with alteplase for acute myocardial infarction. Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators
-
Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators, Oct 16;
-
Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators. A comparison of reteplase with alteplase for acute myocardial infarction. Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators. N Engl J Med 1997 Oct 16; 337: 1118-23
-
(1997)
N Engl J Med
, vol.337
, pp. 1118-1123
-
-
-
16
-
-
33846898686
-
-
Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence. International Joint Efficacy Comparison of Thrombolytics [published erratum appears in Lancet 1995 Oct 7; 346 (8980): 980]. Lancet 1995; 346 (8971): 329-36
-
Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence. International Joint Efficacy Comparison of Thrombolytics [published erratum appears in Lancet 1995 Oct 7; 346 (8980): 980]. Lancet 1995; 346 (8971): 329-36
-
-
-
-
17
-
-
10944239058
-
ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction)
-
Aug 31;
-
Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004 Aug 31; 110 (9): e82-292
-
(2004)
Circulation
, vol.110
, Issue.9
-
-
Antman, E.M.1
Anbe, D.T.2
Armstrong, P.W.3
-
18
-
-
0037014565
-
Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction: Results of the Early Retavase-Thrombolysis In Myocardial Infarction (ER-TIMI) 19 Trial. The Early Retavase-Thrombolysis In Myocardial Infarction (ER-TIMI) 19 Investigators
-
Jul 3;
-
Morrow DA, Antman EM, Sayah A, et al. Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction: results of the Early Retavase-Thrombolysis In Myocardial Infarction (ER-TIMI) 19 Trial. The Early Retavase-Thrombolysis In Myocardial Infarction (ER-TIMI) 19 Investigators. J Am Coll Cardiol 2002 Jul 3; 40: 71-7
-
(2002)
J Am Coll Cardiol
, vol.40
, pp. 71-77
-
-
Morrow, D.A.1
Antman, E.M.2
Sayah, A.3
-
19
-
-
0035897888
-
Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: The GUSTO V randomised trial
-
The GUSTO V Investigators, Jun 16;
-
The GUSTO V Investigators. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. Lancet 2001 Jun 16; 357: 1905-14
-
(2001)
Lancet
, vol.357
, pp. 1905-1914
-
-
-
20
-
-
0037032380
-
Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial. The GUSTO V Investigators
-
Nov 6;
-
Lincoff AM, Califf RM, Van de Werf F, et al. Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial. The GUSTO V Investigators. JAMA 2002 Nov 6; 288: 2130-5
-
(2002)
JAMA
, vol.288
, pp. 2130-2135
-
-
Lincoff, A.M.1
Califf, R.M.2
Van de Werf, F.3
-
21
-
-
0034332695
-
Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: Results from the SPEED (GUSTO-4 Pilot) trial
-
Nov 1;
-
Herrmann HC, Moliterno DJ, Ohman EM, et al. Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: results from the SPEED (GUSTO-4 Pilot) trial. J Am Coll Cardiol 2000 Nov 1; 36: 1489-96
-
(2000)
J Am Coll Cardiol
, vol.36
, pp. 1489-1496
-
-
Herrmann, H.C.1
Moliterno, D.J.2
Ohman, E.M.3
-
22
-
-
0036847872
-
Declining-dose study of reteplase treatment for lower extremity arterial occlusions
-
Nov;
-
Castaneda F, Swischuk JL, Li RZ, et al. Declining-dose study of reteplase treatment for lower extremity arterial occlusions. J Vasc Interv Radiol 2002 Nov; 13: 1093-8
-
(2002)
J Vasc Interv Radiol
, vol.13
, pp. 1093-1098
-
-
Castaneda, F.1
Swischuk, J.L.2
Li, R.Z.3
-
23
-
-
1542313878
-
Reteplase monotherapy and reteplase/abciximab combination therapy in peripheral arterial occlusive disease: Results from the RELAX trial
-
Mar;
-
Ouriel K, Castaneda F, McNamara T, et al. Reteplase monotherapy and reteplase/abciximab combination therapy in peripheral arterial occlusive disease: results from the RELAX trial. J Vasc Interv Radiol 2004 Mar; 15 (3): 229-38
-
(2004)
J Vasc Interv Radiol
, vol.15
, Issue.3
, pp. 229-238
-
-
Ouriel, K.1
Castaneda, F.2
McNamara, T.3
-
24
-
-
33744805092
-
Peripheral arteries: Treatment with antibodies of platelet receptors and reteplase for thrombolysis: APART trial
-
Tepe G, Hopfenzitz C, Dietz K, et al. Peripheral arteries: treatment with antibodies of platelet receptors and reteplase for thrombolysis: APART trial. Radiology 2006; 239 (3): 892-900
-
(2006)
Radiology
, vol.239
, Issue.3
, pp. 892-900
-
-
Tepe, G.1
Hopfenzitz, C.2
Dietz, K.3
-
25
-
-
33846917095
-
Intraarterial reteplase infusion for acute stroke intervention: Inital experience [abstract no. 31]
-
Barr JD, Loges R, Magdinec M. Intraarterial reteplase infusion for acute stroke intervention: inital experience [abstract no. 31]. J Vasc Interv Radiol 2000; 12 (2 Pt 2): S13
-
(2000)
J Vasc Interv Radiol
, vol.12
, Issue.2 PART 2
-
-
Barr, J.D.1
Loges, R.2
Magdinec, M.3
-
26
-
-
0034978362
-
Intra-arterial third-generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke
-
Jul;
-
Qureshi AI, Ali Z, Suri MFK, et al. Intra-arterial third-generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke. Neurosurgery 2001 Jul; 49: 41-8
-
(2001)
Neurosurgery
, vol.49
, pp. 41-48
-
-
Qureshi, A.I.1
Ali, Z.2
Suri, M.F.K.3
-
27
-
-
0036871178
-
Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: A prospective study
-
Nov;, discussion 1327-9
-
Qureshi AI, Siddiqui AM, Suri MF, et al. Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: a prospective study. Neurosurgery 2002 Nov; 51 (5): 1319-27; discussion 1327-9
-
(2002)
Neurosurgery
, vol.51
, Issue.5
, pp. 1319-1327
-
-
Qureshi, A.I.1
Siddiqui, A.M.2
Suri, M.F.3
-
28
-
-
1242316383
-
Reocclusion of recanalized arteries during intra-arterial thrombolysis for acute ischemic stroke
-
Feb;
-
Qureshi AI, Siddiqui AM, Kim SH, et al. Reocclusion of recanalized arteries during intra-arterial thrombolysis for acute ischemic stroke. Am J Neuroradiol 2004 Feb; 25 (2): 322-8
-
(2004)
Am J Neuroradiol
, vol.25
, Issue.2
, pp. 322-328
-
-
Qureshi, A.I.1
Siddiqui, A.M.2
Kim, S.H.3
-
29
-
-
33846899633
-
A prospective study to assess the safety and efficacy of intra-arterial reteplase and intravenous abciximab in patients with acute ischemic stroke
-
Feb 1;
-
Qureshi AI, Kirmani JF, Janjua N, et al. A prospective study to assess the safety and efficacy of intra-arterial reteplase and intravenous abciximab in patients with acute ischemic stroke. Stroke 2006 Feb 1; 37 (2): 705
-
(2006)
Stroke
, vol.37
, Issue.2
, pp. 705
-
-
Qureshi, A.I.1
Kirmani, J.F.2
Janjua, N.3
-
30
-
-
33846926479
-
Reopro Retavse Reperfusion of Stroke Safety Study - Imaging Evaluation (ROSIE): Interim safety and efficacy results
-
abstract no. LB1, Feb 16-18; Kissimmee FL
-
Warach S, Butman J, Davis L, et al. Reopro Retavse Reperfusion of Stroke Safety Study - Imaging Evaluation (ROSIE): interim safety and efficacy results [abstract no. LB1]. International Stroke Conference; 2006 Feb 16-18; Kissimmee (FL)
-
(2006)
International Stroke Conference
-
-
Warach, S.1
Butman, J.2
Davis, L.3
-
31
-
-
1642577004
-
Efficacy and safety of reteplase for central venous catheter occlusion in patients with cancer
-
Jan;
-
Liu CY, Jain V, Shields AF, et al. Efficacy and safety of reteplase for central venous catheter occlusion in patients with cancer. J Vasc Interv Radiol 2004 Jan; 15 (1 Pt 1): 39-44
-
(2004)
J Vasc Interv Radiol
, vol.15
, Issue.1 PART 1
, pp. 39-44
-
-
Liu, C.Y.1
Jain, V.2
Shields, A.F.3
-
32
-
-
0036708493
-
Reteplase for clearance of occluded venous catheters
-
Sep 1;
-
Owens L. Reteplase for clearance of occluded venous catheters. Am J Health Syst Pharm 2002 Sep 1; 59 (17): 1638-40
-
(2002)
Am J Health Syst Pharm
, vol.59
, Issue.17
, pp. 1638-1640
-
-
Owens, L.1
-
33
-
-
0035427948
-
The efficacy of reteplase in the treatment of thrombosed hemodialysis venous catheters
-
Aug;
-
Castner D. The efficacy of reteplase in the treatment of thrombosed hemodialysis venous catheters. Nephrol Nurs J 2001 Aug; 28 (4): 403-19
-
(2001)
Nephrol Nurs J
, vol.28
, Issue.4
, pp. 403-419
-
-
Castner, D.1
-
34
-
-
0347135833
-
Efficacy of reteplase in poorly functioning hemodialysis catheters
-
Jan;
-
Falk A, Samson W, Uribarri J, et al. Efficacy of reteplase in poorly functioning hemodialysis catheters. Clin Nephrol 2004 Jan; 61 (1): 47-53
-
(2004)
Clin Nephrol
, vol.61
, Issue.1
, pp. 47-53
-
-
Falk, A.1
Samson, W.2
Uribarri, J.3
-
35
-
-
1842579552
-
The efficacy and safety of reteplase for thrombolysis of hemodialysis catheters at a community and academic regional medical center
-
Hyman G, England M, Kibede S, et al. The efficacy and safety of reteplase for thrombolysis of hemodialysis catheters at a community and academic regional medical center. Nephron Clin Pract 2004; 96 (2): c39-42
-
(2004)
Nephron Clin Pract
, vol.96
, Issue.2
-
-
Hyman, G.1
England, M.2
Kibede, S.3
-
36
-
-
0242693182
-
Safety, dose, and timing of reteplase in treating occluded central venous catheters in children with cancer
-
Nov;
-
Terrill KR, Lemons RS, Goldsby RE. Safety, dose, and timing of reteplase in treating occluded central venous catheters in children with cancer. J Pediatr Hematol Oncol 2003 Nov; 25 (11): 864-7
-
(2003)
J Pediatr Hematol Oncol
, vol.25
, Issue.11
, pp. 864-867
-
-
Terrill, K.R.1
Lemons, R.S.2
Goldsby, R.E.3
-
37
-
-
0037318513
-
Reteplase for dysfunctional hemodialysis catheter clearance
-
Feb;
-
Hilleman DE, Dunlay RW, Packard KA. Reteplase for dysfunctional hemodialysis catheter clearance. Pharmacotherapy 2003 Feb; 23: 137-41
-
(2003)
Pharmacotherapy
, vol.23
, pp. 137-141
-
-
Hilleman, D.E.1
Dunlay, R.W.2
Packard, K.A.3
-
38
-
-
33846929573
-
Pulse-spray pharmacomechanical thrombolysis (PSPMT) of clotted hemodialysis grafts with reteplase (RPA) [abstract no. 321]
-
Hilleman DE, Lanspa TJ, Lenz TL. Pulse-spray pharmacomechanical thrombolysis (PSPMT) of clotted hemodialysis grafts with reteplase (RPA) [abstract no. 321]. J Vasc Interv Radiol 2002; 13 (2 Pt 2): S109
-
(2002)
J Vasc Interv Radiol
, vol.13
, Issue.2 PART 2
-
-
Hilleman, D.E.1
Lanspa, T.J.2
Lenz, T.L.3
-
39
-
-
0000978974
-
Percutaneous thrombolysis of hemodialysis grafts using reteplase [abstract no. 202]
-
Gibbens D, Depalma J, Albanese J, et al. Percutaneous thrombolysis of hemodialysis grafts using reteplase [abstract no. 202]. J Vasc Interv Radiol 2000; 11 (2 Pt 2): 250
-
(2000)
J Vasc Interv Radiol
, vol.11
, Issue.2 PART 2
, pp. 250
-
-
Gibbens, D.1
Depalma, J.2
Albanese, J.3
-
40
-
-
0001698314
-
Initial experience with reteplase using the 'lyse and wait' technique in thrombosed dialysis grafts [abstract no. 207]
-
Flick PA, Das M, Horton K, et al. Initial experience with reteplase using the 'lyse and wait' technique in thrombosed dialysis grafts [abstract no. 207]. J Vasc Interv Radiol 2000; 11 (2 Pt 2): 252
-
(2000)
J Vasc Interv Radiol
, vol.11
, Issue.2 PART 2
, pp. 252
-
-
Flick, P.A.1
Das, M.2
Horton, K.3
-
41
-
-
0032802952
-
Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism
-
Jul;
-
Tebbe U, Graf A, Kamke W, et al. Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism. Am Heart J 1999 Jul; 138 (1 Pt 1): 39-44
-
(1999)
Am Heart J
, vol.138
, Issue.1 PART 1
, pp. 39-44
-
-
Tebbe, U.1
Graf, A.2
Kamke, W.3
-
42
-
-
0142104875
-
Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute mycocardial infarction: Dichotomous response as a function of age in the GUSTO V trial
-
Oct;
-
Savonitto S, Armstrong PW, Lincoff AM, et al. Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute mycocardial infarction: dichotomous response as a function of age in the GUSTO V trial. Eur Heart J 2003 Oct; 24 (20): 1807-14
-
(2003)
Eur Heart J
, vol.24
, Issue.20
, pp. 1807-1814
-
-
Savonitto, S.1
Armstrong, P.W.2
Lincoff, A.M.3
|